Clear Health Introduces Topical Isotretinoin as Alternative to Oral Accutane

Key Takeaways

Clear Health launches Isoclear, a topical skincare regimen with isotretinoin, targeted at acne treatment without iPLEDGE enrollment.
Isoclear comprises three components: Clear, Fade, and Renew, priced at $100 for a two-month supply.
The regimen expands the potential user base from 5-10 million patients needing Accutane to approximately 50 million Americans affected by acne.

Clear Health Introduces Isoclear, a Topical Isotretinoin Regimen

Clear Health is debuting Isoclear, a groundbreaking topical skincare treatment featuring isotretinoin, the principal ingredient in Accutane. This launch aims to overcome concerns surrounding oral medications, reach a broader patient demographic, and stand out in the competitive telehealth market. The company claims Isoclear is the first topical isotretinoin regimen available in the United States.

Isoclear consists of three active components: Clear focuses on reducing breakouts by addressing clogged pores, bacteria, and inflammation; Fade targets discoloration and uneven skin tone brought on by acne; and Renew supports ongoing skin health. With a cost of $100 for a two-month supply or $480 annually, it is designed to be financially accessible to customers.

Despite its long-standing reputation and effectiveness, isotretinoin has faced scrutiny due to its side effects and the stringent safety protocols of the iPLEDGE program by the U.S. Food and Drug Administration, which mandates ongoing pregnancy testing for female patients to prevent birth defects during treatment. Isoclear offers patients an alternative method to access isotretinoin without navigating these requirements.

Michael Chang, CEO and co-founder of Clear Health, emphasizes the need for a more patient-friendly option. He notes that many potential patients are discouraged from pursuing isotretinoin due to the iPLEDGE enrollment process.

As a prescription medication, Isoclear requires prior consultation with a dermatologist but eliminates the burdens of ongoing monitoring typically associated with oral isotretinoin. Clear Health boasts that it can connect patients to dermatologists across all 50 states within 24 hours, enhancing accessibility.

By introducing Isoclear, Clear Health aims to expand its potential audience from the 5-10 million Americans deemed suitable for Accutane to around 50 million, considering that approximately 85% of adolescents and up to 30% of adults experience acne. The median age of Clear Health’s patients is around 30, indicating a significant interest among adults seeking lasting solutions.

Chang clarifies that while patients may see results within weeks of using Isoclear, it is not a substitute for the medication’s oral form nor intended as an acne cure. However, there is potential for some users to transition to oral isotretinoin after experiencing Isoclear. To ease this path, Clear Health guarantees coverage for the first oral consultation and month of medication if users do not achieve satisfactory results after four months on Isoclear.

Despite previous attempts to launch topical isotretinoin in the U.S. being hindered by formulation challenges, advancements in technology are allowing Clear Health to successfully offer a stable product. The company believes that Isoclear can address tolerability issues associated with existing retinoid treatments.

Accompanying the product launch, Clear Health plans an advertising campaign on YouTube, Meta, and TikTok, potentially extending to streaming platforms. This campaign features Chang and dermatologist Aaron Farberg, targeting individuals seeking enhanced acne treatment options.

Clear Health sees Isoclear as a significant development that could ultimately become the backbone of its business, aiming for broader patient engagement beyond the confines of oral prescriptions. According to Diana Melencio, a general partner at XRC Ventures, the introduction of Isoclear solidifies Clear Health’s commitment to fostering long-term relationships with patients throughout their skincare journey.

In a crowded telehealth landscape, Chang believes that building a strong brand will ensure sustained success, emphasizing that brand affinity will have lasting impacts more than intellectual property protections.

The content above is a summary. For more details, see the source article.